| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| venBio Global Strategic Fund III, L.P. | 10%+ Owner | $322 M | Sep 19, 2023 | ||
| Redmile Group, LLC | 10%+ Owner | $116 M | Sep 19, 2023 | ||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%+ Owner | $97.4 M | Sep 19, 2023 | ||
| Richard A. Heyman | Director | $0 | Feb 26, 2024 | ||
| Kenneth Song | PRESIDENT AND CHIEF EXECUTIVE, Director | $0 | Feb 26, 2024 | ||
| Viking Global Investors Lp | 10%+ Owner | $0 | Feb 26, 2024 | ||
| Maha Katabi | Director | $0 | Feb 26, 2024 | ||
| Susan Moran | Chief Medical Officer | $0 | Feb 26, 2024 | ||
| Arvind Kush | Chief Financial Officer | $0 | Feb 26, 2024 | ||
| Timothy Van Hauwermeiren | Director | Feb 26, 2024 | |||
| Aaron Royston | Director | Sep 14, 2023 | |||
| Versant Ventures VII GP-GP, LLC | 10%+ Owner | Sep 14, 2023 | |||
| Yi Larson | Director | Feb 26, 2024 | |||
| Christy J. Oliger | Director | Feb 26, 2024 | |||
| Mary Tagliaferri | Director | Feb 26, 2024 | |||
| Angie You | Director | Feb 26, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|